LMK Servicos Medicos SS

Porto Alegre, Rio Grande do Sul 90480-000

2 studies enrolling now · 9 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), Covid19, Idiopathic Inflammatory Myositis, Lupus Erythematosus, Systemic, Lupus Nephritis, Sjogren's Syndrome, Sjögren's Syndrome, Sjögren's Syndrome (SS)

Studies at this site

• A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Recruiting now
• A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) — Recruiting now
• A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) — Completed
• A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity — Running, not enrolling
• A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State — Running, not enrolling
• Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN) — Stopped early
• The Prevent Severe COVID-19 (PRESECO) Study — Completed
• A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus — Completed